On January 31, 2024 Sumitomo Dainippon Pharma reported Summary of Consolidated Financial Results for the Third Quarter of the Year Ending March 31, 2024 (Press release, Sumitomo Dainippon Pharma, JAN 31, 2024, View Source [SID1234643772]).
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!